Cancer Treatment Centers of America is one of the leading hospital systems in treating cancer patients. To expand their treatment methods, they recently partnered with Allscripts and NantHealth to launch a new comprehensive oncology treatment platform called Clinical Pathways.
The first Cancer Treatment Centers of America (CTCA) hospital opened in 1988 in Illinois. Since then, they have opened four more hospitals across the country. CTCA has become renowned for its advancements in treating every type of cancer. The doctors and staff at CTCA locations work only with cancer patients, allowing them to dedicate their time to each patient and give them personalized care. With state-of-the-art technology and innovative medical approaches, CTCA is able to guide cancer patients through their treatment.
Partnering with Allscripts, an electronic health record system and Nanthealth, a health care data company, CTCA has designed a technological advancement that will help its patients make critical decisions about their care. Clinical Pathways presents patients with a selection of treatment options that have been customized to the CTCA standard. The selection presented to each patient will be tailored to their specific needs based on recent research, treatment regimens and complimentary therapies. Clinical Pathways will make it easier for patients to deliberate treatment options with their healthcare teams.
In addition to assisting patients, Clinical Pathways presents a system where doctors can access the latest cancer research and literature. CTCA currently has over 200 doctors, specializing in over 50 different oncology areas. With Clinical Pathways, these doctors can access an unbiased, evidence-based medical library with over 2,700 peer-reviewed, evidence-based treatment regimens for all cancers and cancer subtypes.
With this new platform, CTCA will be able to widen its scope on diagnosing and treating cancer patients. Clinical Pathways is currently available to patients at all five Cancer Treatment Centers of America locations.
For more information follow CTCA on Facebook.